Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

INTRODUCTION: Blood-based next-generation sequencing assays of circulating tumor DNA (ctDNA) have the ability to detect tumor-associated mutations in patients with SCLC. We sought to characterize the relationship between ctDNA mean variant allele frequency (VAF) and radiographic total-body tumor vol...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Jarrod T., Balar, Aneri, Lakhani, Dhairya A., Kluwe, Christien, Zhao, Zhiguo, Kopparapu, Prasad, Almodovar, Karinna, Muterspaugh, Anel, Yan, Yingjun, York, Sally, Horn, Leora, Antic, Sanja, Bertucci, Caterina, Shaffer, Tristan, Hodsdon, Lauren, Garg, Kavita, Hosseini, Seyed Ali, Lim, Lee, Osmundson, Evan, Massion, Pierre P., Lovly, Christine M., Iams, Wade
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474385/
https://www.ncbi.nlm.nih.gov/pubmed/34589992
http://dx.doi.org/10.1016/j.jtocrr.2020.100110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474385/
https://www.ncbi.nlm.nih.gov/pubmed/34589992
http://dx.doi.org/10.1016/j.jtocrr.2020.100110

Ejemplares similares